Claris gets MHRA OK for injectables plant
Indian manufacturer Claris Lifesciences has had its injectable drug manufacturing facility in Ahmedabad approved by the UK MHRA.
Archives for August 20, 2014
GSK welcomes US OK for Arnuity in light of declining Advair sales
US FDA approval of the inhaled corticosteroid (ICS) asthma drug Arnuity will help offset declining sales of the off-patent bestseller Advair, says GlaxoSmithKline.
How to speed up development: share work with rivals, say scientists
Drug developers should add their early-stage discoveries to an open-source database or pay a fine to cut wasted time duplicating results, say researchers.
Clinverse closes $9m in Series C funding round
Clinverse, a provider of automated financial management tech solutions for clinical trials, has closed a $9.1m (€6.9m) round of funding led by New Jersey-based Edison Partners.
Macfarlan Smith fined $12,000 after accident at API plant
Opiate API manufacturer Macfarlan Smith has been fined £12,000 for failing to ensure the safety of an employee injured at its plant in Scotland in 2011.
Harlan looks to corner NCI grantees lost by Charles River
News of the discontinuation of the National Cancer Institute’s (NCI) Animal Production Program has led Charles River Laboratories rival Harlan to vie for the market of grantees that still need animal research models.
Ben Venue site has no place in injectables network, says new owner Hikma
Ben Venue Laboratories will remain inactive says new owner Hikma as it looks to optimise its injectables manufacturing network.